[HTML][HTML] The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to …

SK Dissanayake, M Wade, CE Johnson… - Journal of Biological …, 2007 - ASBMB
We have shown that Wnt5A increases the motility of melanoma cells. To explore cellular
pathways involving Wnt5A, we compared gain-of-function (WNT5A stable transfectants) …

The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal …

SK Dissanayake, M Wade, CE Johnson… - Journal of …, 2007 - experts.nebraska.edu
We have shown that Wnt5A increases the motility of melanoma cells. To explore cellular
pathways involving Wnt5A, we compared gain-of-function (WNT5A stable transfectants) …

The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal …

SK Dissanayake, M Wade… - Journal of …, 2007 - pure.johnshopkins.edu
We have shown that Wnt5A increases the motility of melanoma cells. To explore cellular
pathways involving Wnt5A, we compared gain-of-function (WNT5A stable transfectants) …

[PDF][PDF] The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to …

SK Dissanayake, M Wade, CE Johnson, MP O'Connell… - J Biol Chem, 2007 - academia.edu
We have shown that Wnt5A increases the motility of melanoma cells. To explore cellular
pathways involving Wnt5A, we compared gain-of-function (WNT5A stable transfectants) …

The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal …

SK Dissanayake, M Wade, CE Johnson… - The Journal of …, 2007 - europepmc.org
We have shown that Wnt5A increases the motility of melanoma cells. To explore cellular
pathways involving Wnt5A, we compared gain-of-function (WNT5A stable transfectants) …

[引用][C] The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to …

S DISSANAYAKE - J Biol Chem, 2007 - cir.nii.ac.jp
The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of
metastasis suppressors and initiation of an epithelial to mesenchymal transition | CiNii …

[HTML][HTML] The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to …

SK Dissanayake, M Wade, CE Johnson… - Journal of Biological …, 2007 - Elsevier
We have shown that Wnt5A increases the motility of melanoma cells. To explore cellular
pathways involving Wnt5A, we compared gain-of-function (WNT5A stable transfectants) …

[HTML][HTML] The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to …

SK Dissanayake, M Wade, CE Johnson… - The Journal of …, 2007 - ncbi.nlm.nih.gov
We have shown that Wnt5A increases the motility of melanoma cells. To explore cellular
pathways involving Wnt5A, we compared gain-of-function (WNT5A stable transfectants) …

[PDF][PDF] The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to …

SK Dissanayake, M Wade, CE Johnson… - J Biol …, 2007 - researchgate.net
We have shown that Wnt5A increases the motility of melanoma cells. To explore cellular
pathways involving Wnt5A, we compared gain-of-function (WNT5A stable transfectants) …

The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal …

SK Dissanayake, M Wade… - The Journal of …, 2007 - pubmed.ncbi.nlm.nih.gov
We have shown that Wnt5A increases the motility of melanoma cells. To explore cellular
pathways involving Wnt5A, we compared gain-of-function (WNT5A stable transfectants) …